Nuveen’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$181M Sell
2,122,546
-180,725
-8% -$16.1M 0.05% 274
2025
Q4
$182M Buy
2,303,271
+381,043
+20% +$29.9M 0.05% 284
2025
Q3
$154M Buy
1,922,228
+18,226
+1% +$1.55M 0.04% 306
2025
Q2
$173M Sell
1,904,002
-418,232
-18% -$38.2M 0.05% 277
2025
Q1
$218M Sell
2,322,234
-642,330
-22% -$57.5M 0.07% 241
2024
Q4
$270M Sell
2,964,564
-168,921
-5% -$16.1M 0.08% 213
2024
Q3
$325M Buy
3,133,485
+484,385
+18% +$49.4M 0.09% 184
2024
Q2
$257M Buy
2,649,100
+44,352
+2% +$4.09M 0.08% 207
2024
Q1
$235M Sell
2,604,748
-34,176
-1% -$2.9M 0.07% 234
2023
Q4
$210M Sell
2,638,924
-707,149
-21% -$53.2M 0.07% 234
2023
Q3
$238M Sell
3,346,073
-743,214
-18% -$55.6M 0.08% 198
2023
Q2
$315M Buy
4,089,287
+509,527
+14% +$39.4M 0.11% 160
2023
Q1
$269M Sell
3,579,760
-3,344
-0.1% -$249K 0.1% 183
2022
Q4
$282M Sell
3,583,104
-454,256
-11% -$34.1M 0.11% 178
2022
Q3
$284M Buy
4,037,360
+4,160
+0.1% +$326K 0.11% 166
2022
Q2
$323M Buy
4,033,200
+593,180
+17% +$46.4M 0.13% 151
2022
Q1
$255M Buy
3,440,020
+24,032
+0.7% +$1.9M 0.08% 217
2021
Q4
$292M Sell
3,415,988
-355,392
-9% -$27.8M 0.09% 214
2021
Q3
$285M Sell
3,771,380
-2,315,194
-38% -$184M 0.09% 210
2021
Q2
$495M Buy
6,086,574
+142,167
+2% +$11.6M 0.15% 132
2021
Q1
$469M Buy
5,944,407
+128,030
+2% +$10M 0.15% 133
2020
Q4
$497M Sell
5,816,377
-48,393
-0.8% -$4M 0.17% 121
2020
Q3
$452M Sell
5,864,770
-476,338
-8% -$36.3M 0.17% 122
2020
Q2
$465M Sell
6,341,108
-1,615,775
-20% -$115M 0.19% 104
2020
Q1
$528M Buy
7,956,883
+1,394,544
+21% +$98.4M 0.26% 84
2019
Q4
$452M Sell
6,562,339
-7,786
-0.1% -$531K 0.17% 120
2019
Q3
$483M Buy
6,570,125
+135,018
+2% +$9.8M 0.2% 109
2019
Q2
$461M Buy
6,435,107
+6,395,426
+16,117% +$454M 0.18% 108
2019
Q1
$2.72M Buy
+39,681
New +$2.56M 0.01% 604
2018
Q3
Sell
-4,164
Closed -$270K 1036
2018
Q2
$270K Sell
4,164
-40,247
-91% -$2.63M ﹤0.01% 981
2018
Q1
$3.18M Sell
44,411
-713
-2% -$51.3K 0.02% 527
2017
Q4
$3.4M Buy
45,124
+3,257
+8% +$238K 0.02% 510
2017
Q3
$3.05M Buy
41,867
+21,687
+107% +$1.56M 0.02% 553
2017
Q2
$1.5M Sell
20,180
-23,598
-54% -$1.75M 0.01% 666
2017
Q1
$3.2M Sell
43,778
-133,126
-75% -$9.32M 0.02% 582
2016
Q4
$11.6M Sell
176,904
-11,450
-6% -$785K 0.06% 412
2016
Q3
$14M Sell
188,354
-3,988
-2% -$295K 0.08% 295
2016
Q2
$14.1M Buy
192,342
+112,163
+140% +$7.99M 0.09% 282
2016
Q1
$5.67K Buy
80,179
+9,901
+14% +$659K 0.03% 451
2015
Q4
$4.68K Sell
70,278
-584
-0.8% -$38.8K 0.02% 482
2015
Q3
$4.5K Sell
70,862
-890
-1% -$58.1K 0.03% 511
2015
Q2
$4.69K Buy
71,752
+1,033
+1% +$70.1K 0.03% 541
2015
Q1
$4.9M Buy
70,719
+1,225
+2% +$84.7K 0.03% 528
2014
Q4
$4.81M Buy
69,494
+8,362
+14% +$565K 0.03% 559
2014
Q3
$3.99M Sell
61,132
-17
-0% -$1.12K 0.02% 607
2014
Q2
$4.17M Sell
61,149
-5,180
-8% -$347K 0.03% 586
2014
Q1
$4.3M Sell
66,329
-2,200
-3% -$139K 0.03% 569
2013
Q4
$4.47M Sell
68,529
-2,763
-4% -$177K 0.03% 539
2013
Q3
$4.23M Buy
71,292
+2,067
+3% +$122K 0.03% 562
2013
Q2
$3.97M Buy
+69,225
New +$4.11M 0.03% 566

Other funds holding CL

Nuveen's CL Position: Q1 2026 in Review

Nuveen reduced its Colgate-Palmolive (CL) stake by 7.8% in Q1 2026, selling an estimated $16.1M and leaving 2,122,546 shares worth $181M. The position accounts for 0.05% of the portfolio, ranked #274.

Nuveen first reported a position in CL in Q2 2013 and has held it in 50 quarters since. The position peaked at $528M in Q1 2020. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Nuveen held 2,122,546 shares of Colgate-Palmolive worth $181M as of Q1 2026.
  • Nuveen sold 180,725 Colgate-Palmolive shares in Q1 2026, an estimated $16.1M.
  • Colgate-Palmolive made up 0.05% of Nuveen's portfolio in Q1 2026, its #274 holding.
  • Nuveen first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 50 quarters since.
  • Nuveen's Colgate-Palmolive position peaked at $528M in Q1 2020.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.